Abstract Details
Activity Number:
|
479
|
Type:
|
Topic Contributed
|
Date/Time:
|
Wednesday, August 12, 2015 : 8:30 AM to 10:20 AM
|
Sponsor:
|
Biopharmaceutical Section
|
Abstract #315636
|
View Presentation
|
Title:
|
Joint Optimization of Phase II and Phase III Designs When One or Two Doses Can Be Carried into Phase III
|
Author(s):
|
Nitin Patel* and James Bolognese and Jaydeep Bhattacharyya
|
Companies:
|
Cytel Inc. and Cytel Inc. and Cytel Inc.
|
Keywords:
|
Program Optimization ;
Phase 2 ;
Phase 3 ;
Clinical trials ;
Neuropathic Pain ;
More than one dose
|
Abstract:
|
In past work we have shown the value of program level optimization of Phase 2 and Phase 3 clinical trial designs for neuropathic pain (Patel N et.al. 'Designing Phase 2 Trials Based on Program-Level Considerations: A Case Study for Neuropathic Pain', Drug Information Journal, 2012, 46 (4) 439-454). The objective in that publication was to maximize Expected Net Present Value (ENPV) of the program while taking into account both efficacy and safety considerations. In this talk we will discuss extensions of that work to carrying two doses into Phase 3 when Phase 2 results indicate sufficient separation in efficacy between them in addition to meeting efficacy and safety targets. We consider situations where results may require additional Phase 3 programs for regulatory approval to enable taking two doses to market. In addition to the objective of maximizing ENPV we examine optimization with the objective of maximizing clinical utility.
|
Authors who are presenting talks have a * after their name.
Back to the full JSM 2015 program
|
For program information, contact the JSM Registration Department or phone (888) 231-3473.
For Professional Development information, contact the Education Department.
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
2015 JSM Online Program Home
ASA Meetings Department
732 North Washington Street, Alexandria, VA 22314
(703) 684-1221 • meetings@amstat.org
Copyright © American Statistical Association.